MTOR and diabetes mellitus: In addition, medical factors such as diabetes [10], high body mass index (BMI), delayed graft function (DGF) [12], use of mammalian target of rapamycin (mTOR) inhibitors [1,13,14,15] and acute rejection have been associated with lymphocele formation [1,10,16].